The Oncosearch | Oncotarget

Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma Research Paper

Laila Babar, Juliann E. Kosovec, Vida Jahangiri, Nobel Chowdhury, Ping Zheng, Ashten N. Omstead, Madison S. Salvitti, Matthew A. Smith, Ajay Goel, Ronan J. Kelly, Blair A. Jobe, Ali H. Zaidi

Published Jul 16, 2019 · Vol. 10, No. 44 · pp. 4546-4555

Keywords: esophageal adenocarcinoma, LAG3, IDO1, CXCL9, TIM3

Semi-automated analysis of digital whole slides from humanized lung-cancer xenograft models for checkpoint inhibitor response prediction Research Paper

Daniel Bug, Friedrich Feuerhake, Eva Oswald, Julia Schüler, Dorit Merhof

Published Jul 16, 2019 · Vol. 10, No. 44 · pp. 4587-4597

Keywords: deep learning, digital pathology, histology, non small cell lung cancer, xenograft

Cell-free DNA in newly diagnosed patients with glioblastoma – a clinical prospective feasibility study Research Paper

Dorte Schou Nørøxe, Olga Østrup, Christina Westmose Yde, Lise Barlebo Ahlborn, Finn Cilius Nielsen, Signe Regner Michaelsen, Vibeke Andrée Larsen, Jane Skjøth-Rasmussen, Jannick Brennum, Petra Hamerlik, Hans Skovgaard Poulsen, Ulrik Lassen

Published Jul 9, 2019 · Vol. 10, No. 43 · pp. 4397-4406

Keywords: glioblastoma, liquid biopsy, cell-free DNA, fragment length, base-pair

EWS-FLI1 low Ewing sarcoma cells demonstrate decreased susceptibility to T-cell-mediated tumor cell apoptosis Research Paper

Kelly M. Bailey, Claire M. Julian, Ariel N. Klinghoffer, Heather Bernard, Peter C. Lucas, Linda M. McAllister-Lucas

Published May 21, 2019 · Vol. 10, No. 36 · pp. 3385-3399

Keywords: EWS-FLI1, Ewing sarcoma, T-cell, interferon, apoptosis

Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumab Case Report

Anna Kathrin StÃ¼ven, Bertram Wiedenmann

Published May 14, 2019 · Vol. 10, No. 35 · pp. 3302-3311

Comparative safety analysis of immunotherapy combined with chemotherapy versus monotherapy in solid tumors: a meta-analysis of randomized clinical trials Review

Alberto Carretero-González, David Lora, Ismael Ghanem, Irene Otero, Flora López, Daniel Castellano, Guillermo de Velasco

Published May 14, 2019 · Vol. 10, No. 35 · pp. 3294-3301

Keywords: immunotherapy, chemotherapy, combination treatment, safety profile, adverse events

Programmed cell death ligand 1 (PD-L1) blockade attenuates metastatic colon cancer growth in cAMP-response element-binding protein (CREB)-binding protein (CBP)/β-catenin inhibitor-treated livers Research Paper

Yosuke Osawa, Ekumi Kojika, Koji Nishikawa, Masamichi Kimura, Shigenori Osakaya, Hiromi Miyauchi, Tatsuya Kanto, Yutaka Kawakami, Kiminori Kimura

Published Apr 30, 2019 · Vol. 10, No. 32 · pp. 3013-3026

Keywords: PD-L1, β-catenin, CBP, colon cancer, metastatic liver cancer

Phase I study of local radiation and tremelimumab in patients with inoperable locally recurrent or metastatic breast cancer Research Paper

Di (Maria) Jiang, Anthony Fyles, Linh T. Nguyen, Benjamin G. Neel, Adrian Sacher, Robert Rottapel, Ben X. Wang, Pamela S. Ohashi, Srikala S. Sridhar

Published Apr 26, 2019 · Vol. 10, No. 31 · pp. 2947-2958

Keywords: radiation, immunotherapy, breast cancer, anti-CTLA-4

Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic risk Research Paper

Erika J. Lampert, John L. Hays, Elise C. Kohn, Christina M. Annunziata, Lori Minasian, Minshu Yu, Nicolas Gordon, Tristan M. Sissung, Victoria L. Chiou, William D. Figg, Nicole Houston, Jung-Min Lee

Published Apr 23, 2019 · Vol. 10, No. 30 · pp. 2855-2868

Keywords: high-grade serous ovarian cancer, BRCA wild type, olaparib, carboplatin

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-mutant mammary tumours Research Paper

Liliana D. Ordonez, Trevor Hay, Robert McEwen, Urszula M. Polanska, Adina Hughes, Oona Delpuech, Elaine Cadogan, Steve Powell, Jonathan Dry, Giusy Tornillo, Lucy Silcock, Elisabetta Leo, Mark J. O’Connor, Alan R. Clarke, Matthew J. Smalley

Published Apr 5, 2019 · Vol. 10, No. 27 · pp. 2586-2606

Keywords: PARP inhibitors, olaparib, Brca2, EMT, P-gps

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper

Liliana D. Ordonez, Trevor Hay, Robert McEwen, Urszula M. Polanska, Adina Hughes, Oona Delpuech, Elaine Cadogan, Steve Powell, Jonathan Dry, Giusy Tornillo, Lucy Silcock, Elisabetta Leo, Mark J. O’Connor, Alan R. Clarke, Matthew J. Smalley

Published Mar 27, 2019

Keywords: PARP inhibitors, olaparib, Brca2, EMT, P-gps

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper

Liliana D. Ordonez, Trevor Hay, Robert McEwen, Urszula M. Polanska, Adina Hughes, Oona Delpuech, Elaine Cadogan, Steve Powell, Jonathan Dry, Giusy Tornillo, Lucy Silcock, Elisabetta Leo, Mark J. O’Connor, Alan R. Clarke, Matthew J. Smalley

Published Mar 27, 2019

Keywords: PARP inhibitors, olaparib, Brca2, EMT, P-gps

PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor models Research Paper

Leah A. Mitchell, Kader Yagiz, Andrew Hofacre, Sophie Viaud, Anthony W. Munday, Fernando Lopez Espinoza, Daniel Mendoza, Maria E. Rodriguez-Aguirre, Simon Bergqvist, Ali Haghighi, Marin V. Miner, William P. Accomando, Cynthia Burrascano, Dawn Gammon, Harry E. Gruber, Douglas J. Jolly, Amy H. Lin

Published Mar 19, 2019 · Vol. 10, No. 23 · pp. 2252-2269

Keywords: immunotherapy, single chain variable fragment, retroviral replicating vector, PD-L1, PD-1

The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma Research Paper

Benjamin J. Chen, Ravi Dashnamoorthy, Pallavi Galera, Vladislav Makarenko, Hong Chang, Srimoyee Ghosh, Andrew M. Evens

Published Mar 12, 2019 · Vol. 10, No. 21 · pp. 2030-2040

Keywords: lymphoma, immunotherapy, immune checkpoint, TIM-3, LAG-3

Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer Research Paper

Clelia Madeddu, Paraskevas Kotsonis, Fabrizio Lavra, Giacomo Chiappe, Luca Melis, Ester Mura, Mario Scartozzi, Antonio Macciò

Published Mar 12, 2019 · Vol. 10, No. 21 · pp. 2012-2021

Keywords: laparoscopic total pelvic exenteratio, immunotherapy, synchronous cancer, cervical cancer, next-generation sequencing

PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-Î³ Research Paper

Masami Iwasa, Takeshi Harada, Asuka Oda, Ariunzaya Bat-Erdene, Jumpei Teramachi, Hirofumi Tenshin, Mohannad Ashtar, Masahiro Oura, Kimiko Sogabe, Kengo Udaka, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Shuji Ozaki, Masahiro Abe

Published Mar 8, 2019 · Vol. 10, No. 20 · pp. 1903-1917

POLE Score: a comprehensive profiling of programmed death 1 ligand 1 expression in pancreatic ductal adenocarcinoma Research Paper

Sascha Rahn, Sandra KrÃ¼ger, Ruben Mennrich, Lisa Goebel, Daniela Wesch, Hans-Heinrich Oberg, Ilka Vogel, Michael Ebsen, Christoph RÃ¶cken, Ole Helm, Susanne Sebens

Published Feb 22, 2019 · Vol. 10, No. 16 · pp. 1572-1588

Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice Research Paper

Lasse Neukirch, Tea Kirkegaard Nielsen, Henriette Laursen, Joana Daradoumis, Christian Thirion, Peter Johannes Holst

Published Feb 15, 2019 · Vol. 10, No. 14 · pp. 1458-1472

Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models Research Paper

Steven A. Greenberg, Sek Won Kong, Evan Thompson, Stefano V. Gulla

Published Feb 15, 2019 · Vol. 10, No. 14 · pp. 1399-1406

Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and γ-irradiation in human glioblastoma cells Research Paper

Vladimir N. Ivanov, Jinhua Wu, Tony J.C. Wang, Tom K. Hei

Published Jan 25, 2019 · Vol. 10, No. 8 · pp. 825-846

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma Research Paper

Semi-automated analysis of digital whole slides from humanized lung-cancer xenograft models for checkpoint inhibitor response prediction Research Paper

Cell-free DNA in newly diagnosed patients with glioblastoma – a clinical prospective feasibility study Research Paper

EWS-FLI1 low Ewing sarcoma cells demonstrate decreased susceptibility to T-cell-mediated tumor cell apoptosis Research Paper

Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumab Case Report

Comparative safety analysis of immunotherapy combined with chemotherapy versus monotherapy in solid tumors: a meta-analysis of randomized clinical trials Review

Programmed cell death ligand 1 (PD-L1) blockade attenuates metastatic colon cancer growth in cAMP-response element-binding protein (CREB)-binding protein (CBP)/β-catenin inhibitor-treated livers Research Paper

Phase I study of local radiation and tremelimumab in patients with inoperable locally recurrent or metastatic breast cancer Research Paper

Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic risk Research Paper

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-mutant mammary tumours Research Paper

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper

PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor models Research Paper

The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma Research Paper

Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer Research Paper

PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-Î³ Research Paper

POLE Score: a comprehensive profiling of programmed death 1 ligand 1 expression in pancreatic ductal adenocarcinoma Research Paper

Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice Research Paper

Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models Research Paper

Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and γ-irradiation in human glioblastoma cells Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma Research Paper

Semi-automated analysis of digital whole slides from humanized lung-cancer xenograft models for checkpoint inhibitor response prediction Research Paper

Cell-free DNA in newly diagnosed patients with glioblastoma – a clinical prospective feasibility study Research Paper

EWS-FLI1 low Ewing sarcoma cells demonstrate decreased susceptibility to T-cell-mediated tumor cell apoptosis Research Paper

Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumab Case Report

Comparative safety analysis of immunotherapy combined with chemotherapy versus monotherapy in solid tumors: a meta-analysis of randomized clinical trials Review

Programmed cell death ligand 1 (PD-L1) blockade attenuates metastatic colon cancer growth in cAMP-response element-binding protein (CREB)-binding protein (CBP)/β-catenin inhibitor-treated livers Research Paper

Phase I study of local radiation and tremelimumab in patients with inoperable locally recurrent or metastatic breast cancer Research Paper

Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic risk Research Paper

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-mutant mammary tumours Research Paper

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper

PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor models Research Paper

The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma Research Paper

Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer Research Paper

PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-Î³ Research Paper

POLE Score: a comprehensive profiling of programmed death 1 ligand 1 expression in pancreatic ductal adenocarcinoma Research Paper

Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice Research Paper

Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models Research Paper

Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and γ-irradiation in human glioblastoma cells Research Paper